Fujimoto A, Ichinose Y, Matsuura K, Mikami E, et al. Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response in Triple-Negative Breast Cancer Treated With Neoadjuvant Pembrolizumab Plus Chemotherapy. Clin Breast Cancer 2026;26:52-57.
PMID: 42731392